Wilson-Noble v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedAugust 5, 2024
Docket21-1518V
StatusUnpublished

This text of Wilson-Noble v. Secretary of Health and Human Services (Wilson-Noble v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wilson-Noble v. Secretary of Health and Human Services, (uscfc 2024).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 21-1518V Filed: July 11, 2024

* * * * * * * * * * * * * * * ANGELA WILSON-NOBLE, * * Petitioner, * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * *

Michael McLaren, Esq., Black McLaren, PC, Memphis, TN, for petitioner. Catherine Stolar, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On June 29, 2021, Angela Wilson-Noble (“petitioner” or “Ms. Wilson-Noble”) filed a petition for compensation under the National Vaccine Injury Compensation Program2 alleging that she developed Guillain-Barré Syndrome (“GBS”) and/or Acute or Chronic Inflammatory Demyelinating Polyneuropathy (“AIDP” and “CIDP”) as a result of the influenza (“flu”) vaccine she received on October 15, 2019.3 Petition, ECF No. 1. Petitioner now seeks an award of interim attorneys’ fees and costs.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). 3 During a status conference on November 1, 2022, it was discussed that petitioner’s diagnosis in this case is CIDP. ECF No. 40. I. Procedural History

The petition was filed on June 29, 2021, and petitioner filed medical records and a statement of completion on July 1, 2021. Petitioner’s Exhibits (“Pet. Ex.”) 1-17, ECF Nos. 6-10, 12. Petitioner filed additional medical records on August 5, 2021; August 11, 2021; and August 12, 2021. Pet. Ex. 18, ECF No. 14; Pet. Ex. 19-20, ECF No. 15; Pet. Ex. 21, ECF No. 16.

The matter was assigned to the undersigned on December 17, 2021, and petitioner filed additional medical records thereafter on January 31, 2022; February 2, 2022; and February 7, 2022. Pet. Ex. 22, ECF No. 22; Pet. Ex. 23, ECF No. 23; Pet. Ex. 24, ECF No. 24.

On March 28, 2022, respondent filed a status report advising that he was amenable to informal resolution, but on April 12, 2022, after further consideration of the medical records and the onset of petitioner’s CIDP, respondent filed another status report stating that he was no longer interested in informal resolution. ECF Nos. 28-29. Thereafter, on May 27, 2022, respondent filed his Rule 4(c) Report identifying outstanding medical records and recommending against compensation. ECF No. 30.

Petitioner filed medical records and a statement of completion on August 17, 2022. Pet. Ex. 25-27, ECF Nos. 35-36. On October 5, 2022, respondent filed a status report stating that he was satisfied the record sufficiently was complete. ECF No. 38.

A status conference was held on November 1, 2022, after which petitioner was ordered to file an expert report. ECF No. 40. Petitioner filed an expert report, curriculum vitae, and medical literature from Dr. Lawrence Steinman on January 30, 2023. Pet. Ex. 28-58, ECF No. 41.

On June 2, 2023, respondent filed responsive expert reports, curriculum vitae, and medical literature from Dr. Peter Donofrio and Dr. Robert Fujinami. Respondent’s Exhibits (“Resp. Ex.”) A-D, ECF No. 43.

Thereafter, petitioner filed a supplemental report from Dr. Steinman on June 27, 2023, and respondent filed a responsive report from Dr. Donofrio on August 23, 2023. Pet. Ex. 59, ECF No. 44; Resp. Ex. E, ECF No. 45. Petitioner filed a third report from Dr. Steinman on October 27, 2023. Pet. Ex. 60, ECF No. 47.

On December 11, 2023, the parties filed a status report requesting the scheduling of an entitlement hearing. ECF No. 49. Based on the court’s current hearing calendar, a two-day entitlement hearing was scheduled for August 18 and 19, 2026. ECF No. 51.

On February 13, 2024, petitioner filed a Motion for Interim Attorneys’ Fees and Costs. Motion for Interim Fees, ECF No. 54. Petitioner requests a total of $110,756.11, representing $95,763.00 in attorneys’ fees and $14,993.11 in costs. Motion for Interim Fees at 9. Respondent filed a response on February 15, 2024, deferring to the undersigned to determine whether the statutory requirements and legal standard for an award of interim attorneys’ fees and costs were met. Response, ECF No. 56. Petitioner did not file a reply.

2 This matter is now ripe for determination.

II. Legal Framework

The Vaccine Act permits an award of reasonable attorneys’ fees and other costs. § 15(e)(1). If a petitioner succeeds on the merits of his or her claim, petitioner’s counsel is automatically entitled to reasonable attorneys’ fees. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1).

The Federal Circuit has endorsed the use of the lodestar approach to determine what constitutes “reasonable attorneys’ fees” and “other costs” under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1349 (Fed. Cir. 2008). Under this approach, “an initial estimate of a reasonable attorneys’ fee” is calculated by “multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Id. at 1347-48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). That product is then adjusted upward or downward based on other specific findings. Id.

Special masters have substantial discretion in awarding fees and may adjust a fee request sua sponte, apart from objections raised by respondent and without providing petitioners with notice and opportunity to respond. Sabella v. Sec’y of Health & Human Servs., 86 Fed. Cl. 201, 209 (2009). Special masters need not engage in a line-by-line analysis of petitioner’s fee application when reducing fees. Broekelschen v. Sec’y of Health & Human Servs., 102 Fed. Cl. 719, 729 (2011).

III. Discussion

A. Availability of Interim Fees

Special masters have discretion to award interim fees while the litigation is ongoing if “the cost of litigation has imposed an undue hardship” and there is “a good faith basis for the claim.” Shaw v. Sec’y of Health & Human Servs., 609 F. 3d 1372, 1375 (Fed. Cir. 2010); see Avera, 515 F. 3d at 1352. The court in Avera held that interim fees may be awarded “in appropriate circumstances.” Id. at 1351.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Wilson-Noble v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wilson-noble-v-secretary-of-health-and-human-services-uscfc-2024.